Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1993 | 12-1992 | 09-1992 | 03-1992 | 12-1991 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | 27,627 | 0 | 27,627 | 10,073 |
| Depreciation Amortization | 0 | 85,332 | 0 | 85,332 | 93,651 |
| Other Working Capital | 0 | 41,365 | 0 | 41,365 | 21,225 |
| Other Operating Activity | 0 | -12,103 | 0 | -12,103 | -15,212 |
| Operating Cash Flow | $0 | $142,221 | $0 | $142,221 | $109,737 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -100,761 | 0 | -100,761 | -95,333 |
| Net Acquisitions | 0 | -3,611 | 0 | -3,611 | -3,368 |
| Other Investing Activity | 0 | 32,394 | 0 | 32,394 | 28,985 |
| Investing Cash Flow | $0 | $-71,978 | $0 | $-71,978 | $-69,716 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | -77,305 | 0 | -77,305 | -47,654 |
| Financing Cash Flow | $0 | $-77,305 | $0 | $-77,305 | $-47,654 |
| Beginning Cash Position | 0 | 11,376 | 0 | 11,376 | 19,009 |
| End Cash Position | 0 | 4,314 | 0 | 4,314 | 11,376 |
| Net Cash Flow | $0 | $-7,062 | $0 | $-7,062 | $-7,633 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | 142,221 | 0 | 142,221 | 109,737 |
| Free Cash Flow | 0 | 142,221 | 0 | 142,221 | 109,737 |